The Digital Medicine Crystal Ball

May 15, 2017 Erin Righetti

How will digital technologies impact disease management and healthcare over the next decade?

Find out in the just-released whitepaper, “The Digital Medicine Crystal Ball: Unlocking the Future of Real-Time, Precise, Effective, Healthcare.”

The last five years have seen an unprecedented eruption in technological and health advances.

These new technologies and products—many undergoing rigorous clinical validation—will have significant direct impacts on diagnosing, preventing, monitoring or treating a disease, condition or syndrome, which in turn will transform disease management and alter business models across industries.

This whitepaper describes the current and future influence of digital medicine on the health ecosystem and highlights how various stakeholders are working to deliver clinically impactful and economically viable solutions in a saturated yet still-emerging business environment.

Topics addressed in the whitepaper include:

  • How various stakeholders are working to deliver clinically impactful and economically viable solutions in a saturated yet still-emerging business environment
  • The new roles of traditional healthcare players
  • How the entrance of new technologies will affect partnership models and business strategies
  • The future of digital medicine’s regulatory environment

 

Share your email address with EBD Group to open the whitepaper. Unsubscribe to our news at any time. Learn More: EBD Group Terms of Use Privacy Policy

Read more...

About the Author

Erin Righetti

Editor-in-Chief, Insight

Follow on Twitter More Content by Erin Righetti
Previous Article
The Advocate of Rare Disease Advocates: Remembering Henri Termeer
The Advocate of Rare Disease Advocates: Remembering Henri Termeer

We were saddened to come to work Monday morning to discover that innovator, industry giant and Genzyme foun...

Next Article
Tissue regeneration: A vital area within regenerative medicine
Tissue regeneration: A vital area within regenerative medicine

Guest post by Patricia Reilly, M.S., Head of Intelligence Alliances and Unification, Pharma Intelligence an...